# The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL

> **NCT00347737** · NA · WITHDRAWN · sponsor: **Leland Graves III, MD**

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** teriparatide

## Key facts

- **NCT ID:** NCT00347737
- **Lead sponsor:** Leland Graves III, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00347737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00347737, "The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00347737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*